|
Skrivet av Admin2
|
|
2010-04-24 kl. 14:10 |
Amerikanska ASAM (The American Society of Addiction Medicine) har publicerat ett omfattande white paper om så kallad “medicinsk” marijuana.
Modern history of cannabis in medicine
“Medical marijuana” in the United States
Reports from expert bodies
• National Institutes of Health
• Institute of Medicine Report
• Professional organizations
o American Medical Association
o American College of Physicians
o American Nurses Association
• The Federal Position
o The Controlled Substances Act (CSA)
o Federal Departments and Agencies
• Modern medications and the FDA approval process
• “Medical marijuana” and the modern medication model
• What has been tried in other countries?
• Existing research: What do w eknow and wha do we still need to determine?
o Issues for additional research
o Results of controlled clinical trials
• Oral cannabinoid preparations
o Dronabinol
o Cesamet ®
o Cannador ®
• Smoked/vaporized herbal cannabis
• Oromucosal/sublingual cannabis-derived preparations
• Are There Principled Reasons for Exempting Cannabis from the Quality, Safety, and Efficacy Requirements of the Modern Medication Model
o Is cannabis benign? – Risks and side effects
• Could a cannabis preparation achieve FDA approval?
• The significance of scheduling
• Conclusions
• Recommendations
Du kan läsa hela materialet här.
|
|
Senast uppdaterad 2010-04-24 kl. 18:14 |
0 Kommentarer